ZA858951B - Flavolignane derivatives,process for preparation thereof and pharmaceuticals,which contain these combinations - Google Patents

Flavolignane derivatives,process for preparation thereof and pharmaceuticals,which contain these combinations

Info

Publication number
ZA858951B
ZA858951B ZA858951A ZA858951A ZA858951B ZA 858951 B ZA858951 B ZA 858951B ZA 858951 A ZA858951 A ZA 858951A ZA 858951 A ZA858951 A ZA 858951A ZA 858951 B ZA858951 B ZA 858951B
Authority
ZA
South Africa
Prior art keywords
flavolignane
pharmaceuticals
derivatives
combinations
contain
Prior art date
Application number
ZA858951A
Other languages
English (en)
Inventor
Reinhard Braatz
Klaus Goerler
Guenter Halbach
Hartwig Soicke
Karlheinz Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of ZA858951B publication Critical patent/ZA858951B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
ZA858951A 1984-11-22 1985-11-21 Flavolignane derivatives,process for preparation thereof and pharmaceuticals,which contain these combinations ZA858951B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
ZA858951B true ZA858951B (en) 1986-08-27

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA858951A ZA858951B (en) 1984-11-22 1985-11-21 Flavolignane derivatives,process for preparation thereof and pharmaceuticals,which contain these combinations

Country Status (29)

Country Link
JP (1) JPS61143377A (fr)
KR (1) KR870001020B1 (fr)
AR (1) AR240931A1 (fr)
AT (1) AT393268B (fr)
BE (1) BE903693A (fr)
CA (1) CA1337124C (fr)
CH (1) CH659473A5 (fr)
CS (1) CS273610B2 (fr)
DD (1) DD259191A1 (fr)
DE (1) DE3442639A1 (fr)
DK (1) DK164865C (fr)
EG (1) EG19424A (fr)
ES (1) ES8609311A1 (fr)
FI (1) FI84064C (fr)
FR (1) FR2573427B1 (fr)
GB (1) GB2167414B (fr)
HU (1) HU195503B (fr)
IE (1) IE58791B1 (fr)
IT (1) IT1190426B (fr)
LU (1) LU86163A1 (fr)
MX (1) MX168415B (fr)
NL (1) NL192387C (fr)
NO (1) NO160205C (fr)
PL (1) PL146890B1 (fr)
PT (1) PT81532B (fr)
SE (1) SE465676B (fr)
SU (1) SU1436875A3 (fr)
YU (1) YU43689B (fr)
ZA (1) ZA858951B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
ES2552108T3 (es) * 2005-03-11 2015-11-25 Howard Florey Institute Pty Ltd Compuestos flavonoides y usos de los mismos
JP5349486B2 (ja) 2007-11-15 2013-11-20 マダウス ゲーエムベーハー 肝炎の治療のためのシリビニン成分
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
AU2010247716B2 (en) * 2009-05-14 2015-11-05 Madaus Gmbh Amorphous silibinin for the treatment of viral hepatitis
WO2014008353A2 (fr) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprenant du sulforaphane ou un précurseur de sulforaphane et un extrait ou une poudre de champignon
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
CS837885A2 (en) 1990-08-14
JPH0432073B2 (fr) 1992-05-28
GB8528226D0 (en) 1985-12-18
DK537785D0 (da) 1985-11-21
NL192387C (nl) 1997-07-04
DE3442639A1 (de) 1986-05-22
AT393268B (de) 1991-09-25
PT81532A (de) 1985-12-01
FI854535A (fi) 1986-05-23
NO854655L (no) 1986-05-23
SE8505487D0 (sv) 1985-11-20
ES549116A0 (es) 1986-09-01
LU86163A1 (de) 1986-03-24
IE58791B1 (en) 1993-11-17
FI84064C (fi) 1991-10-10
MX168415B (es) 1993-05-24
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
KR860004056A (ko) 1986-06-16
CH659473A5 (de) 1987-01-30
YU43689B (en) 1989-10-31
JPS61143377A (ja) 1986-07-01
IE852808L (en) 1986-05-22
DK164865C (da) 1993-01-18
FI84064B (fi) 1991-06-28
DK164865B (da) 1992-08-31
GB2167414B (en) 1989-01-11
NO160205C (no) 1989-03-22
PL256374A1 (en) 1986-12-02
HU195503B (en) 1988-05-30
FR2573427B1 (fr) 1989-03-10
HUT40114A (en) 1986-11-28
FR2573427A1 (fr) 1986-05-23
DE3442639C2 (fr) 1989-08-10
PT81532B (pt) 1987-11-11
CA1337124C (fr) 1995-09-26
ES8609311A1 (es) 1986-09-01
BE903693A (fr) 1986-05-22
KR870001020B1 (ko) 1987-05-23
DK537785A (da) 1986-05-23
IT8522932A0 (it) 1985-11-21
SU1436875A3 (ru) 1988-11-07
AR240931A2 (es) 1991-03-27
EG19424A (en) 1995-02-28
ATA337185A (de) 1991-02-15
NL8503171A (nl) 1986-06-16
IT1190426B (it) 1988-02-16
FI854535A0 (fi) 1985-11-18
NL192387B (nl) 1997-03-03
DD259191A1 (de) 1988-08-17
GB2167414A (en) 1986-05-29
AR240931A1 (es) 1991-03-27
NO160205B (no) 1988-12-12
SE8505487L (sv) 1986-05-23
CS273610B2 (en) 1991-03-12
YU178685A (en) 1988-02-29

Similar Documents

Publication Publication Date Title
DE3572488D1 (en) Dialkoxyridines, process for their preparation, their application and medicaments containing them
ZA859756B (en) Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
HUT39161A (en) Process for preparing 2-pyridon-derivatives and pharmaceuticals comprising the same
IL75120A0 (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
ZA836072B (en) Desoxyuridine derivatives,processes for their preparation and their use as pharmaceuticals
PH24599A (en) Amonoycyllabdanes, pharmaceutical compositions and a process for the preparations thereof
ZA853667B (en) New benzazephine derivatives,pharmaceutical compositions containing them and processes for their preparation
EP0168005A3 (en) Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
ZA858951B (en) Flavolignane derivatives,process for preparation thereof and pharmaceuticals,which contain these combinations
ZA85487B (en) Azolyl-aryl-alkanol derivatives,processes for their preparation and their use
DE3573428D1 (en) Novel delta4- and delta5- androstene derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives
EP0168042A3 (en) Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them
IL76327A0 (en) Phenylacetonitrile derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
EP0253272A3 (en) Addition compounds, process for their preparation and their application
DE3664635D1 (en) 7-hydroxyguanine compounds, process for preparing said compounds, pharmaceutical composition, and use thereof
DE3571978D1 (en) Imidazolylalkoxyindanic derivatives, a process for preparing them and pharmaceutical composition containing them
DE3561058D1 (en) Hydroxy-thia-alcanes, process for their preparation and their uses
DE3661830D1 (en) 2,4-dichlorothiazole derivatives and process for their preparation
EP0172919A4 (fr) Derives de cephalosporine, leur procede de preparation et leur utilisation pharmaceutique.
DE3574381D1 (en) Xanthinylmethylthiazolidines, process for their preparation and pharmaceutical compositions containing them
ZA826528B (en) Ascochlorin derivatives,process for preparing the same and pharmaceutical composition containing the same
ZA824644B (en) Nitrosourea derivatives, process for preparing the same and pharmaceutical composition containing the same
ZA853375B (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
GB2158434B (en) Process for preparing2,2-bishalomethylpenam derivatives
DE3267376D1 (en) Quinidines, process for their preparation and their pharmaceutical application